Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.

Although patients with higher RIPK1 levels showed a trend toward have higher bone marrow blast percentage, higher IPSS-R risk categories, and lower hemoglobin and platelets, these differences were not significant ( Supplemental Figure S5 ).

also in 53,322 other papers